Biblio

Export 143 results:
[ Author(Desc)] Title Type Year
Filters: First Letter Of Last Name is P  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
P
A. Pedrinolla, Venturelli, M., Fonte, C., Munari, D., Benetti, M. Vittoria, Rudi, D., Tamburin, S., Muti, E., Zanolla, L., Smania, N., and Schena, F., “Exercise Training on Locomotion in Patients with Alzheimer's Disease: A Feasibility Study.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1599-1609, 2018.
C. Xu Peh, Abdin, E., Vaingankar, J. A., Verma, S., Chua, B. Yiang, Sagayadevan, V., Seow, E., Zhang, Y. J., Shahwan, S., Ng, L. Ling, Prince, M., Chong, S. Ann, and Subramaniam, M., “Validation of a Latent Construct for Dementia in a Population-Wide Dataset from Singapore.”, J Alzheimers Dis, vol. 55, no. 2, pp. 823-833, 2017.
T. Pekkala, Hall, A., Mangialasche, F., Kemppainen, N., Mecocci, P., Ngandu, T., Rinne, J. O., Soininen, H., Tuomilehto, J., Kivipelto, M., and Solomon, A., “Association of Peripheral Insulin Resistance and Other Markers of Type 2 Diabetes Mellitus with Brain Amyloid Deposition in Healthy Individuals at Risk of Dementia.”, J Alzheimers Dis, vol. 76, no. 4, pp. 1243-1248, 2020.
T. Pekkala, Hall, A., Lötjönen, J., Mattila, J., Soininen, H., Ngandu, T., Laatikainen, T., Kivipelto, M., and Solomon, A., “Development of a Late-Life Dementia Prediction Index with Supervised Machine Learning in the Population-Based CAIDE Study.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1055-1067, 2017.
I. Pelcher, Puzo, C., Tripodis, Y., Aparicio, H. J., Steinberg, E. G., Phelps, A., Martin, B., Palmisano, J. N., Vassey, E., Lindbergh, C., McKee, A. C., Stein, T. D., Killiany, R. J., Au, R., Kowall, N. W., Stern, R. A., Mez, J., and Alosco, M. L., “Revised Framingham Stroke Risk Profile: Association with Cognitive Status and MRI-Derived Volumetric Measures.”, J Alzheimers Dis, vol. 78, no. 4, pp. 1393-1408, 2020.
G. M. Peloso, Beiser, A. S., DeStefano, A. L., and Seshadri, S., “Genetic Interaction with Plasma Lipids on Alzheimer's Disease in the Framingham Heart Study.”, J Alzheimers Dis, vol. 66, no. 3, pp. 1275-1282, 2018.
Y. Peng, Zhang, L., Zhou, F., Wang, Y., Zhang, X., Fan, J., Li, S., Li, X., and Li, Y., “Scavenging Reactive Oxygen Species Decreases Amyloid-β Levels via Activation of PI3K/Akt/GLUT1 Pathway in N2a/APP695swe Cells.”, J Alzheimers Dis, vol. 90, no. 1, pp. 185-198, 2022.
R. Penninkilampi, Casey, A. - N., Singh, M. Fiatarone, and Brodaty, H., “The Association between Social Engagement, Loneliness, and Risk of Dementia: A Systematic Review and Meta-Analysis.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1619-1633, 2018.
R. Penninkilampi, Brothers, H. M., and Eslick, G. D., “Pharmacological Agents Targeting γ-Secretase Increase Risk of Cancer and Cognitive Decline in Alzheimer's Disease Patients: A Systematic Review and Meta-Analysis.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1395-404, 2016.
W. Penny, Iglesias-Fuster, J., Quiroz, Y. T., Lopera, F. Javier, and Bobes, M. A., “Dynamic Causal Modeling of Preclinical Autosomal-Dominant Alzheimer's Disease.”, J Alzheimers Dis, 2018.
J. Perales, Turró-Garriga, O., Gascón-Bayarri, J., Reñé-Ramírez, R., and Conde-Sala, J. Lluís, “The Longitudinal Association Between a Discrepancy Measure of Anosognosia in Patients with Dementia, Caregiver Burden and Depression.”, J Alzheimers Dis, vol. 53, no. 3, pp. 1133-43, 2016.
C. D. Pereira, Martins, F., Wiltfang, J., Silva, O. A. B. da Cru, and Rebelo, S., “ABC Transporters Are Key Players in Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 2, pp. 463-485, 2018.
V. Pérez-Grijalba, Fandos, N., Canudas, J., Insua, D., Casabona, D., Lacosta, A. M., Montañés, M., Pesini, P., and Sarasa, M., “Validation of Immunoassay-Based Tools for the Comprehensive Quantification of Aβ40 and Aβ42 Peptides in Plasma.”, J Alzheimers Dis, vol. 54, no. 2, pp. 751-62, 2016.
M. Perkins, Wolf, A. B., Chavira, B., Shonebarger, D., Meckel, J. P., Leung, L., Ballina, L., Ly, S., Saini, A., T Jones, B., Vallejo, J., Jentarra, G., and Valla, J., “Altered Energy Metabolism Pathways in the Posterior Cingulate in Young Adult Apolipoprotein E ɛ4 Carriers.”, J Alzheimers Dis, vol. 53, no. 1, pp. 95-106, 2016.
T. Persson, Lattanzio, F., Calvo-Garrido, J., Rimondini, R., Rubio-Rodrigo, M., Sundström, E., Maioli, S., Sandebring-Matton, A., and Cedazo-Minguez, A., “Apolipoprotein E4 Elicits Lysosomal Cathepsin D Release, Decreased Thioredoxin-1 Levels, and Apoptosis.”, J Alzheimers Dis, vol. 56, no. 2, pp. 601-617, 2017.
M. - T. Pertl, Benke, T., Zamarian, L., and Delazer, M., “Effects of Healthy Aging and Mild Cognitive Impairment on a Real-Life Decision-Making Task.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1077-1087, 2017.
J. Perła-Kaján, Włoczkowska, O., Zioła-Frankowska, A., Frankowski, M., A Smith, D., de Jager, C. A., Refsum, H., and Jakubowski, H., “Paraoxonase 1, B Vitamins Supplementation, and Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 81, no. 3, pp. 1211-1229, 2021.
J. Peter, Lahr, J., Minkova, L., Lauer, E., Grothe, M. J., Teipel, S., Köstering, L., Kaller, C. P., Heimbach, B., Hüll, M., Normann, C., Nissen, C., Reis, J., and Klöppel, S., “Contribution of the Cholinergic System to Verbal Memory Performance in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 53, no. 3, pp. 991-1001, 2016.
J. Peter, Schumacher, L. V., Landerer, V., Abdulkadir, A., Kaller, C. P., Lahr, J., and Klöppel, S., “Biological Factors Contributing to the Response to Cognitive Training in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 61, no. 1, pp. 333-345, 2018.
R. Peters, Ee, N., Peters, J., Booth, A., Mudway, I., and Anstey, K. J., “Air Pollution and Dementia: A Systematic Review.”, J Alzheimers Dis, vol. 70, no. s1, pp. S145-S163, 2019.
C. Peters, Bascuñán, D., Opazo, C., and Aguayo, L. G., “Differential Membrane Toxicity of Amyloid-β Fragments by Pore Forming Mechanisms.”, J Alzheimers Dis, vol. 51, no. 3, pp. 689-99, 2016.
C. Peters, Sepúlveda, F. J., Fernández-Pérez, E. J., Peoples, R. W., and Aguayo, L. G., “The Level of NMDA Receptor in the Membrane Modulates Amyloid-β Association and Perforation.”, J Alzheimers Dis, vol. 53, no. 1, pp. 197-207, 2016.
K. E. Peters, Davis, W. A., Taddei, K., Martins, R. N., Masters, C. L., Davis, T. M. E., and Bruce, D. G., “Plasma Amyloid-β Peptides in Type 2 Diabetes: A Matched Case-Control Study.”, J Alzheimers Dis, vol. 56, no. 3, pp. 1127-1133, 2017.
C. Peters-Libeu, Campagna, J., Mitsumori, M., Poksay, K. S., Spilman, P., Sabogal, A., Bredesen, D. E., and John, V., “sAβPPα is a Potent Endogenous Inhibitor of BACE1.”, J Alzheimers Dis, vol. 47, no. 3, pp. 545-55, 2015.
R. C. Petersen, Aisen, P. S., Beckett, L. A., Donohue, M. C., Gamst, A. C., Harvey, D. J., Jack, C. R., Jagust, W. J., Shaw, L. M., Toga, A. W., Trojanowski, J. Q., and Weiner, M. W., “Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization.”, Neurology, vol. 74, no. 3, pp. 201-9, 2010.

Pages